COR · earnings call history
Cencora Q2 FY26 — EPS +7.5%, EPS/OI guidance raised, buybacks resume amid transitory revenue headwinds
Read the briefCencora Q1 FY26 — Strong Specialty Performance and OneOncology Acquisition Drive Raised Guidance
Read the briefCencora Q4 FY25 — Strong Specialty Performance Drives Raised Long-Term Guidance
Read the briefCencora Q1 FY25 — Strong U.S. Performance Drives Raised EPS Guidance
Read the briefBrowse all US companies on the earnings-call register.